Oestrogen Reimagined: A Breakthrough Approach for Metastatic Prostate Cancer

Oestrogen, the oldest systemic therapy ever used for cancer, is now being reintroduced in the form of oestradiol patches to treat metastatic prostate cancer. Dr. Nick James, Professor of Prostate and Bladder Cancer Research at the Institute of Cancer Research and the Royal Marsden Hospital in London discusses how this innovative therapy could become a viable alternative to androgen deprivation.